An expert discusses how hypercortisolism specifically impacts patients with type 2 diabetes, as well as how hyperglycemia from hypercortisolism differs from that typically associated with type 2 diabetes, influencing treatment decisions.
By
Natalie Bellini, DNP, FNP, BC-ADM, CDCES
| Published on February 20, 2025
5 min read
Video content above is prompted by the following: